Pfizer working on cold storage issues to ensure temperature integrity

US pharma giant Pfizer is working out elaborate cold storage plans to ensure temperature integrity of its vaccine that requires to be maintained at -70 degree Celsius. 

Pfizer became the first vaccine maker to seek emergency use authorisation (EUA) from the Drug Controller General of India (DCGI). It applied for approval of its mRNA vaccine candidate, co-developed with BioNTech, on December 4. 

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. 

“Globally, we will be utilising road and air modes of transportation via our carrier partners,” a Pfizer spokesperson said.  

“We have developed packaging and